Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06539169
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:08.155703+00:00
Published At
2024-11-14T00:00:00+00:00
Record Updated At
2024-11-14
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Alpha-Thalassemia", "Beta-Thalassemia", "Amyloidosis", "Amyotrophic Lateral Sclerosis", "Creutzfeld-Jakob Disease", "Cystic Fibrosis", "Duchenne Muscular Dystrophy", "Early-Onset Alzheimer Disease", "Ehlers-Danlos Syndrome", "Huntington Disease", "Gaucher Disease", "GM1 Gangliosidosis", "Myasthenia Gravis", "Pompe Disease", "Sickle Cell Disease", "Transthyretin Amyloid Cardiomyopathy", "Rare Diseases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-11-14"
protocolSection.identificationModule.nctId
"NCT06539169"
protocolSection.identificationModule.officialTitle
"FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Alpha-Thalassemia (protocolSection.conditionsModule.conditions)
  • Beta-Thalassemia (protocolSection.conditionsModule.conditions)
  • Amyloidosis (protocolSection.conditionsModule.conditions)
  • Amyotrophic Lateral Sclerosis (protocolSection.conditionsModule.conditions)
  • Creutzfeld-Jakob Disease (protocolSection.conditionsModule.conditions)
  • Cystic Fibrosis (protocolSection.conditionsModule.conditions)
  • Duchenne Muscular Dystrophy (protocolSection.conditionsModule.conditions)
  • Early-Onset Alzheimer Disease (protocolSection.conditionsModule.conditions)
  • Ehlers-Danlos Syndrome (protocolSection.conditionsModule.conditions)
  • Huntington Disease (protocolSection.conditionsModule.conditions)
  • Gaucher Disease (protocolSection.conditionsModule.conditions)
  • GM1 Gangliosidosis (protocolSection.conditionsModule.conditions)
  • Myasthenia Gravis (protocolSection.conditionsModule.conditions)
  • Pompe Disease (protocolSection.conditionsModule.conditions)
  • Sickle Cell Disease (protocolSection.conditionsModule.conditions)
  • Transthyretin Amyloid Cardiomyopathy (protocolSection.conditionsModule.conditions)
  • Rare Diseases (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.